NCT06726668 is a clinical trial in Shock, sponsored by Assiut University.

Who is sponsoring NCT06726668?

NCT06726668 is sponsored by Assiut University.

What condition does NCT06726668 study?

NCT06726668 studies Shock, Trauma.

Is NCT06726668 still recruiting?

NCT06726668 is currently not yet recruiting. Last updated 10 December 2024.

Last reviewed 2024-12-10 · How we verify

NCT06726668

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Estimating Fluid Requirement in Shocked Traumatic Patients by US on SCV

Not yet recruiting Last updated 10 December 2024

What this trial tests

trial in Shock in 120 participants. Not yet recruiting.

Timeline

1 March 2025

Primary endpoint
1 March 2026

1 June 2026

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	120
Start date	1 March 2025
Primary completion	1 March 2026
Estimated completion	1 June 2026
Sites	1 location across Egypt

Conditions studied

Shock — all drugs for Shock →
Trauma — all drugs for Trauma →

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with Shock or Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Research question Is the ultrasonographic SCV collapsability index effective in estimating fluid requirements in shocked traumatic Patients ? Purpose of the study To evaluate the effectiveness of ultrasonograghic SCV collapsibility index before and after the first hour of resuscitation in estimating the First 24 h of fluid requirement in shocked traumatic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Shock

Currently open trials in the same condition.

NCT07273643 — Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With · recruiting
NCT07009665 — Fluid Management and Individualized Resuscitation in Sepsis · NA · recruiting
NCT06713668 — Augmented Pacing for Shock in the Cardiac Intensive Care Unit · NA · recruiting
NCT06930235 — Effectiveness of Midodrine as an Adjuvant to Norepinephrine in Weaning Critically Ill Patients From Vasopressors · NA · recruiting
NCT06920173 — Pulse Study: Peripheral Use of Low-dose Vasopressors for Safety and Efficacy in the Intensive Care Unit · Phase 2 · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06726668 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 10 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06726668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing